B. Saez Gimenez (Barcelona, Spain), M. Perch (Copenhagen, Denmark)
Serological response following second and third SARS-CoV-2 vaccines in lung transplant recipients
E. Bárczi (Budapest, Hungary), V. Varga (Budapest, Hungary), A. Nagy (Budapest, Hungary), N. Eszes (Budapest, Hungary), Z. Jáky-Kováts (Budapest, Hungary), V. Müller (Budapest, Hungary), A. Bohacs (Budapest, Hungary)
|   |
Covid-19 in lung allograft recipients - better outcomes after vaccination?
M. Oliveira Pinto (Lisboa, Portugal), J. Rodrigues (Lisboa, Portugal), A. Santos (Lisboa, Portugal), L. Semedo (Lisboa, Portugal)
| |
Sotrovimab: a new therapeutic option in lung transplant
R. Gutiérrez-Larraya Sánchez-Andrade (Madrid, Spain), S. Aguado Ibáñez (Madrid, Spain), M. Erro Iribarren (Madrid, Spain), G. Padín Pico (Madrid, Spain), A. Amaral Corgo (Madrid, Spain), B. Baamonde Veiga (Madrid, Spain), M. Lopez Pando (Madrid, Spain), S. Salinas Castillo (Madrid, Spain), M. Aguilar Pérez (Madrid, Spain), R. Laporta Hernández (Madrid, Spain), P. Ussetti Gil (Madrid, Spain), B. Jara Chinarro (Madrid, Spain)
| |
Can SARSCov2 infection drive in an acute rejection in lung transplant recipients?
M. Balaguer Cartagena (Valencia, Spain), T. Beauperthuy Levy (Valencia, Spain), D. Pastor (Valencia, Spain), J. Reig Mezquida (Valencia, Spain), L. Feced (Valencia, Spain), G. Anguera De Francisco (Valencia, Spain), A. García-Ortega (Valencia, Spain), I. Amara (Valencia, Spain), A. Solé Jover (Valencia, Spain)
| |
NK and T cells responses to CMV in patients awaiting for lung transplantation
D. Cavallaro (siena, Italy), L. Bergantini (siena, Italy), M. D'Alessandro (siena, Italy), S. Gangi (siena, Italy), L. Luzzi (siena, Italy), A. Fossi (siena, Italy), P. Paladini (siena, Italy), E. Bargagli (siena, Italy), D. Bennett (siena, Italy)
| |
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients
L. Bergantini (siena, Italy), D. Bennett (siena, Italy), D. Cavallaro (siena, Italy), A. Otranto (siena, Italy), M. D'Alesssandro (siena, Italy), S. Gangi (siena, Italy), L. Luzzi (siena, Italy), P. Paladini (siena, Italy), A. Fossi (siena, Italy), E. Bargagli (siena, Italy)
| |
Impact of Candida spp. contamination of preservation solutions in lung transplantation: a national experience over a 10-year period
C. Noret (Nantes, France), C. Bretonnière (Nantes, France), F. Morio (Nantes, France), T. Degot (Strasbourg, France), V. Bru (Strasbourg, France), C. Picard (Suresnes, France), E. Cardot (Suresnes, France), B. Coiffard (Marseille, France), S. Ranque (Marseille, France), L. Falque (Grenoble, France), M. Cornet (Grenoble, France), P. Gazengel (Le Plessis-Robinson, France), A. Gigandon (Le Plessis-Robinson, France), A. Senechal (Lyon, France), J. Menotti (Lyon, France), V. Bunel (Paris, France), C. Bonnal (Paris, France), A. Leborgne (Toulouse, France), S. Cassaing (Toulouse, France), X. Demant (Bordeaux, France), F. Gabriel (Bordeaux, France), E. Dannaoui (Paris, France), F. Blanc (Nantes, France), A. Tissot (Nantes, France)
| |
Fungal colonisation in lung transplant recipients: A retrospective study from India
O. Tisekar (Hyderabad, India), M. Lalani (Hyderabad, India), V. Rahulan (Hyderabad, India), S. Ravipati (Hyderabad, India), U. Shah (Hyderabad, India), P. Dutta (Hyderabad, India), S. Attawar (Hyderabad, India)
| |
Clinical outcome following lung transplantation in patients with CF colonized with Burkholderia cepacia complex: results from Mater Hospital lung transplant center Dublin.
A. Alameeri (Dublin 4, Ireland), M. Murray (Dublin 4, Ireland)
| |
Tuberculosis while on Lung transplant wait list & on ECMO as bridge to transplant- An ethical and clinical challenge
S. Sharma (Hyderabad(Telangana), India), S. Goda (Hyderabad(Telangana), India), R. Mamilla (Hyderabad(Telangana), India), K. Ali (Hyderabad(Telangana), India), S. Vanguri (Hyderabad(Telangana), India), J. Thacker (Hyderabad(Telangana), India), A. Jindal (Hyderabad(Telangana), India)
| |
Late Breaking Abstract - dd-cfDNA and DSA in the occurrence of acute rejection in lung transplant recipients
P. PEDINI (Marseille, France), S. Casas (Brisbane, United States), B. Coiffard (Marseille, France), J. Chiaroni (Marseille, France), C. Frassati (Marseille, France), M. Reynaud-Gaubert (Marseille, France), C. Picard (Marseille, France)
| |
Late Breaking Abstract - Characterization of chronic lung allograft dysfunction phenotypes using oscillometry
A. Fu (Toronto, Canada), A. Vasileva (Toronto, Canada), N. Hanafi (Toronto, Canada), N. Belousova (Toronto, Canada), J. Wu (Toronto, Canada), S. Rajyam (Hamilton, Canada), Z. Hantos (Toronto, Canada), C. Chow (Toronto, Canada)
| |
Late Breaking Abstract - Safety of oral Nirmatrelvir plus Ritonavir in Lung transplant recipients
O. Straichman (Petach Tikva, Israel), L. Fridkin (Petach Tikva, Israel), I. Bakal (Petach Tikva, Israel), D. Shitenberg (Petach Tikva, Israel), Y. Shostak (Petach Tikva, Israel), M. Heching (Petach Tikva, Israel), S. Amor (Petach Tikva, Israel), D. Rosengarten (Petach Tikva, Israel), Y. Barac (Petach Tikva, Israel), Y. Peysakhovich (Petach Tikva, Israel), A. Atamna (Petach Tikva, Israel), B. Pertzov (Petach Tikva, Israel), M. Kramer (Petach Tikva, Israel)
| |
Late Breaking Abstract - Lung transplant and COVID-19: A single centre experience in Ireland
H. O Brien (Dublin, Ireland), S. Carter (Dublin, Ireland), B. Lynch (Dublin, Ireland), M. Hannan (Dublin, Ireland), S. Winward (Dublin, Ireland), P. Ging (Dublin, Ireland), J. Kleinerova (Dublin, Ireland), P. Riddell (Dublin, Ireland), M. Murray (Dublin, Ireland)
| |